Association of COOH-terminal-binding Protein (CtBP) and MEF2-interacting Transcription Repressor (MITR) Contributes to Transcriptional Repression of the MEF2 Transcription Factor*

Chun Li Zhang, Timothy A. McKinseyDagger, Jian-rong Lu, and Eric N. Olson§

From the Department of Molecular Biology, The University of Texas Southwestern Medical Center, Dallas, Texas 75390-9148

Received for publication, August 14, 2000



    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The class II histone deacetylases (HDACs) 4, 5, and 7 share a common structural organization, with a carboxyl-terminal catalytic domain and an amino-terminal extension that mediates interactions with members of the myocyte enhancer factor-2 (MEF2) family of transcription factors. Association of these HDACs with MEF2 factors represses transcription of MEF2 target genes. MEF2-interacting transcription repressor (MITR) shares homology with the amino-terminal extensions of class II HDACs and also acts as a transcriptional repressor, but lacks a histone deacetylase catalytic domain. This suggests that MITR represses transcription by recruiting other corepressors. We show that the amino-terminal regions of MITR and class II HDACs interact with the transcriptional corepressor, COOH-terminal-binding protein (CtBP), through a CtBP-binding motif (P-X-D-L-R) conserved in MITR and HDACs 4, 5, and 7. Mutation of this sequence in MITR abolishes interaction with CtBP and impairs, but does not eliminate, the ability of MITR to inhibit MEF2-dependent transcription. The residual repressive activity of MITR mutants that fail to bind CtBP can be attributed to association with other HDAC family members. These findings reveal CtBP-dependent and -independent mechanisms for transcriptional repression by MITR and show that MITR represses MEF2 activity through recruitment of multicomponent corepressor complexes that include CtBP and HDACs.



    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Regulation of chromatin structure is a central mechanism for the control of gene expression and modulation of the acetylation state of nucleosomal histones has been revealed as a dynamic mechanism for chromatin remodeling (reviewed in Ref. 1). Acetylation of the amino-terminal tails of core histones by histone acetyltransferases results in chromatin relaxation and transcriptional activation, whereas deacetylation of histones by histone deacetylases (HDACs)1 is associated with transcriptional repression. Recruitment of histone acetyltransferases and HDACs by DNA-bound transcription factors results in the formation of multiprotein transcription regulatory complexes that confer cell type specificity and signal-dependent regulation to arrays of subordinate genes. There is also evidence that direct acetylation/deacetylation of certain transcription factors provides a mechanism for reversible regulation of transcription.

HDACs can be divided into two classes, I and II, on the basis of size, sequence homology, and formation of distinct complexes. Class I includes HDACs 1, 2, and 3, which are expressed ubiquitously (2-5). Class II includes HDACs 4, 5, 6, and 7, which contain a conserved domain of several hundred amino acids extending amino-terminal from the carboxyl-terminal catalytic domain (6-10). Class II HDACs are tissue-restricted, with especially high levels of expression in heart, skeletal muscle, and brain. MEF2-interacting transcription repressor (MITR) (11), also called HDAC-related protein (HDRP) (12), shares homology with the amino-terminal extension of class II HDACs, but lacks a carboxyl-terminal catalytic domain.

Class II HDACs and MITR/HDRP have been shown to interact with members of the MEF2 family of MADS (MCM1, Agamous, Deficiens, serum response factor) box transcription factors, resulting in transcriptional repression (7, 8, 11, 13, 14). MEF2 factors play central roles in the control of muscle differentiation and have been implicated in growth factor signaling and apoptotic pathways (reviewed in Ref. 15). Thus, negative regulation of MEF2 activity by association with HDACs may inhibit growth and/or differentiation, depending on cell type and the presence of other cofactors for MEF2 and HDACs.

While HDACs are presumed to inhibit transcription as a consequence of their deacetylase activity, the mechanism whereby MITR represses transcription is unclear. MITR has been shown to interact with HDAC1, which could account for its ability to repress MEF2-dependent transcription (11). Consistent with this conclusion, the HDAC inhibitor trichostatin (TSA) has been reported to partially attenuate transcriptional repression by MITR (11). However, another study reported that TSA had no effect on transcriptional repression by MITR, concluding that its mechanism for repression did not involve other HDACs (12).

Here we report that HDACs 4 and 5 and MITR associate with the transcriptional corepressor COOH-terminal binding protein (CtBP) via a CtBP-binding motif (P-X-D-L-R) conserved in HDACs 4, 5, and 7 and MITR. Mutation of this sequence abolishes association of CtBP with MITR and substantially diminishes, but does not eliminate, the transcriptional repression of basal as well as MEF2-dependent promoters by MITR. These results demonstrate that MITR and class II HDACs act as a bridge linking the CtBP corepressor to target transcription factors, such as MEF2, thereby establishing a multiprotein corepressor complex directed at specific downstream genes.


    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Yeast Two-hybrid Screen-- A mouse 17-day embryo MATCHMAKER cDNA library (CLONTECH) was screened with GAL4-HDAC4 bait in the yeast two-hybrid system, as described previously (16). The bait contained amino acids 1-640 of human HDAC4 fused to the GAL4 DNA binding domain. Positive clones were subjected to specificity tests using the GAL4 DNA binding domain alone as bait. Those clones that were specific for interaction with GAL4-HDAC4 bait were sequenced.

Cloning of Mouse MITR-- A mouse expressed sequence tag encoding MITR (GenBankTM accession number AV118321), identified by searching the data base, was used to screen a mouse embryonic day 10.5 cDNA library (Stratagene) for cDNAs encompassing the complete open reading frame. The deduced open reading frame of mouse MITR is 586 amino acids and shows 94 and 66% identity to human and Xenopus MITR proteins, respectively (11, 12). The nucleotide sequence of mouse MITR has been deposited in the data base (GenBankTM accession number AF324492).

Cell Culture, Plasmids, and Transfections-- 10T1/2, COS, and 293T cells were maintained in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum, 2 mM L-glutamine, and penicillin-streptomycin. Transfections were performed using the lipid-based reagent Fugene 6 (Roche Molecular Biochemicals) and cells growing at a density of 5-10 × 105 cells/35-mm dish. Epitope-tagged derivatives of CtBP, MITR, HDAC4, and HDAC5, containing amino-terminal FLAG or Myc tags, were generated using the pcDNA3.1 expression vector (Invitrogen). Expression plasmids for carboxyl-terminally FLAG-tagged HDAC1 (pBJ) and HDAC3 (pcDNA6) were kindly provided by Dr. Stuart Schreiber (Harvard). For GAL4-dependent reporter assays, 10T1/2 cells were cotransfected with a luciferase reporter plasmid under control of four GAL4 DNA binding sites and the thymidine kinase (tk) promoter, pMH100-tk-luc (17), pM1-based expression vectors encoding MITR or MITR(DL-AS) fused to the GAL4 DNA binding domain, and a CMV-lacZ (Invitrogen) plasmid to normalize for variable transfection efficiency. For MEF2-dependent transcription assays, 10T1/2 cells were transfected with a luciferase reporter plasmid under control of three copies of a consensus MEF2 binding site, 3×MEF-luc, a pcDNA1-based expression plasmid (Invitrogen) for MEF2C, pcDNA3.1-based expression vectors encoding either MITR or MITR(DL-AS), and the CMV-lacZ plasmid. Cells were harvested 48 h after transfection, and luciferase and beta -galactosidase activities were measured under conditions of linearity with respect to time and extract concentration.

GST Interaction Assays-- CtBP protein was translated in vitro using the TNT kit (Promega) and a pcDNA3.1-based expression plasmid encoding full-length mouse CtBP1. GST-HDAC and GST-MITR fusion proteins were expressed in the BL21(DE3) strain of Escherichia coli using the pGEX-KG vector (Amersham Pharmacia Biotech). Ten microliters of in vitro translated, [35S]methionine-labeled CtBP (~10,000 cpm) were incubated with GST-HDAC4 and GST-MITR proteins bound to glutathione-agarose beads (Sigma) in GST binding buffer (20 mM Tris, pH 7.3, 150 mM NaCl, 0.5% Nonidet P-40, and protease inhibitors (Complete; Roche Molecular Biochemicals)) for 1 h at 4 °C. Beads were collected by centrifugation and washed five times in GST binding buffer. Bound proteins were resolved by SDS-PAGE and analyzed by autoradiography.

Coimmunoprecipitation Assays-- For coimmunoprecipitation experiments, transiently transfected COS or 293T cells were harvested 48 h following transfection in phosphate-buffered saline containing 0.5% Triton X-100, 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, and protease inhibitors. After brief sonication and removal of cellular debris by centrifugation, FLAG-tagged proteins were immunoprecipitated from cell lysates using anti-FLAG affinity resin (Sigma) and washed five times with lysis buffer. Alternatively, Myc-tagged proteins were immunoprecipitated using polyclonal anti-Myc antibodies (Santa Cruz; A-14) and protein A-Sepharose beads (Zymed Laboratories Inc.). Precipitated proteins were separated by SDS-PAGE, transferred to polyvinylidene fluoride membranes, and immunoblotted with either a monoclonal anti-Myc antibody (Santa Cruz; 9E10) or a monoclonal anti-FLAG antibody (Sigma; M2). Proteins were visualized with a chemiluminescence system (Santa Cruz).


    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Interaction between HDAC4 and CtBP in the Yeast Two-hybrid System-- HDACs 4, 5, and 7 are bipartite, with an amino-terminal region that contains a MEF2-binding motif, and a carboxyl-terminal catalytic region (Fig. 1A). In previous studies, we (13) and others (7, 8, 11, 14) showed that association of HDACs 4, 5, and 7 with MEF2 is mediated by a conserved 18-amino acid motif near their amino-termini. This motif is also conserved in MITR/HDRP, which lacks a catalytic domain.



View larger version (28K):
[in this window]
[in a new window]
 
Fig. 1.   Schematic diagrams of class II HDACs and MITR. A, schematic diagrams of MITR and class II HDACs. B, amino acid sequences of human (h) and mouse (m) HDACs and MITR with the CtBP-binding motif shown in black.

To further investigate the functions of the amino-terminal extension of class II HDACs and MITR, we performed yeast two-hybrid screens using amino acids 1-640 of HDAC4 fused to the GAL4 DNA binding domain as bait (Fig. 1A). Three strong positives obtained from a mouse 17-day embryo cDNA library corresponded to CtBP1, a widely expressed transcriptional corepressor (18, 19). Two independent cDNA clones encoded the entire 441-amino acid CtBP1 protein; the other encoded amino acids 25-441. These CtBP-GAL4 activation domain fusion proteins interacted specifically with the HDAC4 bait and not with the GAL4 DNA binding domain alone (see "Experimental Procedures").

Because CtBP has been shown to interact with the consensus motif P-X-D-L-S/R (20, 21), we scanned the 640-amino acid region of HDAC4 used as bait and identified a potential CtBP-binding motif between residues 48 and 52 (Fig. 1B). Similar sequences were also found in HDACs 5 and 7 and MITR (Fig. 1B). The amino acid sequences surrounding this potential CtBP-binding motif were not conserved in the different HDACs or MITR.

Association of CtBP with MITR and HDACs in Vivo and in Vitro-- The possible association of CtBP with MITR and HDACs was tested further by coimmunoprecipitation assays from transfected cells. As shown in Fig. 2A, HDACs 4 and 5, as well as MITR, were coimmunoprecipitated with CtBP.



View larger version (33K):
[in this window]
[in a new window]
 
Fig. 2.   Association of class II HDACs and MITR with CtBP in vivo and in vitro. A, 293T cells were cotransfected with expression vectors encoding FLAG-tagged CtBP and the indicated Myc-tagged derivatives of HDAC4, HDAC5, or MITR (1 µg each). Myc-tagged proteins were immunoprecipitated from cell lysates with a polyclonal anti-Myc antibody, and coimmunoprecipitating FLAG-tagged proteins were detected by immunoblotting with a monoclonal anti-FLAG antibody (upper panel). The membrane was reprobed with an anti-Myc monoclonal antibody to reveal total immunoprecipitated HDAC or MITR protein (bottom panel). Mock-transfected cells were included as a negative control. B, GST-HDAC and GST-MITR fusion proteins were conjugated to glutathione-agarose beads and incubated with [35S]methionine-labeled CtBP, as described under "Experimental Procedures." After washing and recovery of the beads, associated proteins were resolved by SDS-PAGE and analyzed by autoradiography. In lane 1, 10% of the input [35S]methionine-labeled CtBP was applied directly to the gel. The positions of molecular weight markers are indicated to the left. C, schematic representations of MITR proteins and summary of their interactions with CtBP. D, cells were cotransfected with expression vectors encoding FLAG-tagged CtBP and the indicated Myc-tagged derivatives of MITR (1 µg each). Myc-tagged proteins were immunoprecipitated from cell lysates with a polyclonal anti-Myc antibody, and coimmunoprecipitating FLAG-tagged proteins were detected by immunoblotting with a monoclonal anti-FLAG antibody (upper panel). The membrane was reprobed with an anti-Myc monoclonal antibody to reveal total immunoprecipitated MITR protein (bottom panel). Mock-transfected cells were included as a negative control. E, 293T cells were transfected with expression vectors (1 µg each) for the indicated HDAC5 constructs (left-hand panels, FLAG-tagged; right-hand panels, Myc-tagged) and CtBP (left-hand panels, Myc-tagged; right-hand panels, FLAG-tagged). HDAC5 was immunoprecipitated from cell lysates, and coimmunoprecipitating CtBP was detected by immunoblotting (upper panels). The membranes were reprobed with the appropriate antibodies to reveal total immunoprecipitated HDAC5 (lower panel).

To further test the interaction of CtBP with HDACs and MITR, we performed binding assays with GST fusion proteins. As shown in Fig. 2B, a GST fusion protein containing amino acids 1-60 of HDAC4 (GST-HDAC4-(1-60)), including the CtBP-binding motif, interacted with [35S]methionine-labeled CtBP translated in vitro, whereas amino acids 49-223 of HDAC4 (GST-HDAC4-(49-223)), which contains a truncated CtBP-binding motif, did not interact with CtBP. GST-MITR and GST-HDAC5 also interacted with CtBP (Fig. 2B and data not shown). Residues 1-201 of MITR (GST-MITR-(1-201)) contained the CtBP-binding region, whereas residues 131-586 (GST-MITR-(131-586)) did not bind CtBP (Fig. 2B). A further amino-terminal deletion mutant containing only the first 45 amino acids (GST-MITR-(1-45)) also interacted with CtBP.

To determine specifically whether the P-X-D-L-R motif (residues 23-27) of MITR was responsible for all CtBP-binding activity, we mutated residues DL to AS, which has been shown previously to abolish CtBP binding to the E1a oncoprotein (20). This mutant, GST-MITR-(1-201DL-AS) showed no CtBP binding activity (Fig. 2B). GST alone also showed no interaction with MITR or HDAC4, further establishing the specificity of the observed interactions. The results of the GST pulldown experiments are summarized in Fig. 2C.

The regions of MITR and HDAC5 responsible for recruitment of CtBP were also assayed by coimmunoprecipitation assays in transfected 293T cells. As observed in the GST binding assays, the interaction of MITR with CtBP required the CtBP-binding motif between residues 23 and 27 and was abolished by the DL-AS mutation of this motif (Fig. 2D). In contrast, mutation of the corresponding region of HDAC5 (mutant HDAC5-(EL-AS)) did not prevent its association of CtBP (Fig. 2E). This result suggested that HDAC5 contained additional CtBP-binding motifs. Indeed, a deletion mutant containing residues 121-664, which lacked the CtBP consensus binding motif at the analogous position to that in MITR, also bound CtBP (Fig. 2E), indicating the presence of an additional CtBP-binding motif in this region of the protein. We conclude that CtBP is specifically recruited to MITR through interaction with the P-X-D-L-R motif, which is also conserved in the amino-terminal region of class II HDACs. However, additional regions of HDAC5 can also recruit CtBP.

Association of CtBP Enhances Transcriptional Repression by MITR-- To investigate the potential significance of CtBP binding to MITR, we compared the repressive activity of wild-type MITR and MITR mutant DL-AS, which failed to bind CtBP. As shown in Fig. 3A, wild-type MITR fused to the GAL4 DNA binding domain potently repressed transcription of a GAL4-dependent luciferase reporter linked to the highly active thymidine kinase promoter. GAL4-MITR(DL-AS) also repressed this reporter, but the level of repression was reduced by at least 50% over a 30-fold range of expression plasmid. Wild-type and mutant forms of MITR were expressed at comparable levels in transfected cells (Fig. 2D).



View larger version (13K):
[in this window]
[in a new window]
 
Fig. 3.   The CtBP-binding motif in MITR is required for maximal MITR-mediated transcriptional repression. A, 10T1/2 fibroblasts were transiently cotransfected with a GAL4-dependent luciferase reporter plasmid, pMH100-tk-luc (0.4 µg), expression vectors (10-300 ng) for either GAL4-MITR or GAL4-MITR(DL-AS), and a CMV-lacZ control plasmid (0.1 µg). Forty-eight hours later, cells were harvested and luciferase, and beta -galactosidase activities were measured under conditions of linearity with respect to time and extract concentration. The luciferase values were normalized to beta -galactosidase activity to control for differences in transfection efficiency. B, 10T1/2 fibroblasts were transiently cotransfected with a luciferase reporter plasmid driven by three copies of a MEF2 binding site, 3×MEF2-luciferase (0.3 µg), and expression vectors for MEF2C (0.3 µg), and either MITR (0.1 µg) or MITR(DL-AS) (0.1 µg). Luciferase activity in cell extracts was measured 48 h post-transfection as described above. For A and B, luciferase activity is depicted as -fold repression of the reporter gene in cells expressing GAL4-MITR or GAL4-MITR(DL-AS) relative to activity in cells lacking ectopic MITR. Values represent the mean ± S.D. from at least two separate experiments.

Because MITR has been shown to repress MEF2-dependent transcription (11), we compared the abilities of wild-type MITR and MITR(DL-AS) to repress activation of a luciferase reporter linked to three tandem copies of the MEF2 consensus sequence. Consistent with the results obtained with GAL4-MITR fusions, the MITR(DL-AS) mutant was compromised in its ability to repress transcription, although it clearly retained repressive activity (Fig. 3B).

Association of MITR with Class I and Class II HDACs-- The ability of MITR(DL-AS) to repress transcription in the absence of CtBP binding suggests the existence of redundant, CtBP-independent mechanisms for MITR-mediated repression. Consistent with this, MITR has been shown to interact with HDAC1 (11). Coimmunoprecipitation experiments were performed to determine whether MITR(DL-AS) retained the capacity to bind HDAC1. As shown in Fig. 4A, both wild-type MITR and MITR(DL-AS) efficiently associated with HDAC1 in transfected cells. Furthermore, both proteins interacted with another class I HDAC, HDAC3, as well as the class II HDACs 4 and 5. Homodimeric MITR complexes were also detected in this assay. These results demonstrate that MITR possesses the capacity to associate with multiple HDACs, independent of CtBP binding, and suggest the existence of CtBP-dependent and -independent mechanisms for transcriptional repression by MITR.



View larger version (47K):
[in this window]
[in a new window]
 
Fig. 4.   Association of MITR with class I and class II HDACs. 293T cells were transiently cotransfected with expression vectors encoding Myc-tagged MITR (0.75 µg) or MITR(DL-AS) (0.75 µg) and FLAG-tagged versions of the indicated HDACs (0.75 µg). Alternatively, cells were transfected with the Myc-MITR expression vector (0.75 µg) in the absence of an HDAC expression plasmid (Mock). Cells were harvested 48 h post-transfection, and FLAG-tagged proteins were immunoprecipitated from cell lysates using anti-FLAG affinity resin. Precipitated proteins were resolved by SDS-PAGE and transferred to polyvinylidene difluoride membranes. Membranes were immunoblotted with anti-Myc antibodies to reveal MITR-HDAC interactions (upper panels) and subsequently with anti-FLAG antibodies to control for HDAC expression levels (bottom panels). The positions of molecular weight markers are indicated to the left of each image.



    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The results of this study demonstrate that MITR and class II HDACs share homology in an amino-terminal CtBP-binding motif that recruits CtBP to enhance transcriptional repression. Mutations in this CtBP-binding motif that disrupt CtBP binding diminish the ability of MITR to repress transcription, but such mutants retain substantial repressive activity. Thus, we conclude that recruitment of CtBP by MITR contributes to transcriptional repression. However, maximal inhibition of transcription by MITR, as well as class II HDACs, likely involves the cooperative action of CtBP and deacetylase activity provided in trans by associated HDACs. Indeed, we show that MITR is able to physically associate with several different class I and II HDACs.

CtBP1, first identified as a cellular protein that bound to the carboxyl-terminal region of the E1a oncoprotein (18, 19), acts as a transcriptional corepressor through association with the consensus sequence P-X-D-L-S/R, found in a variety of transcription factors (20-28). CtBP1 and the closely related CtBP2 are expressed in a wide range of tissues. The precise mechanism for transcriptional repression by CtBP is unclear. Other corepressors, such as NcoR and SMRT, repress transcription by recruiting HDACs (9, 10). CtBP1 has also been shown to interact with HDAC1 (27), and TSA has been shown to partially relieve repression by CtBP. However, other studies have found that promoters repressed by CtBP are insensitive to TSA (29), suggesting the existence of HDAC-independent mechanisms for repression by CtBP.

The results of the present study provide the first demonstration of a direct interaction between CtBP and class II HDACs. Class II HDACs can physically associate with class I HDACs, and both types of HDACs can interact with CtBP. Thus, it is clear that each of these proteins has the capacity to serve as a bridge to the other, with the potential to generate repression complexes that are linked to DNA-bound transcription factors such as MEF2.

In contrast to the ubiquitous expression of CtBP, MITR and class II HDACs are expressed predominantly in heart, skeletal muscle, and brain (6, 30, 31), the same tissues in which MEF2 expression is highest (32, 33). While CtBP played only a partial role in MITR-mediated transcriptional repression in our assays, in other cell backgrounds, its contribution to the repressive activity of MITR could be greater, if for example other trans-acting HDACs were expressed at lower levels or were less active due to intracellular signals (13).

It is becoming increasingly clear that HDACs associate with a complex array of cell-specific and ubiquitous transcriptional activators and repressors to control gene expression of large sets of downstream genes. In this regard, a role for these multiprotein complexes in the regulation of cell differentiation is strongly supported by our recent demonstration that class II HDACs, including HDAC4 and HDAC5, potently repress the transcriptional program required for skeletal muscle development (34, 35). This inhibitory action of HDAC is absolutely dependent on its association with MEF2 and can be overcome by calcium/calmodulin-dependent protein kinase signaling, which disrupts MEF2·HDAC complexes (13, 34). Understanding in molecular terms how HDAC·CtBP-containing complexes regulate divergent gene programs will require identification of the many components of these transcriptional complexes and elucidation of the mechanisms by which they are regulated by cell identity and signaling systems.


    ACKNOWLEDGEMENTS

We are grateful to A. Tizenor for graphics and J. Page for editorial assistance.


    FOOTNOTES

* This work was supported by grants from the National Institutes of Heath, The Robert A. Welch Foundation, and The D. W. Reynolds Foundation (to E. N. O).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF324492.

Dagger Supported as a Pfizer fellow of The Life Sciences Research Foundation.

§ To whom correspondence should be addressed. Tel.: 214-648-1187; Fax: 214-648-1196; E-mail:eolson@hamon.swmed.edu.

Published, JBC Papers in Press, October 5, 2000, DOI 10.1074/jbc.M007364200


    ABBREVIATIONS

The abbreviations used are: HDAC, histone deacetylase; CtBP, COOH-terminal-binding protein; HDRP, HDAC-related protein; MEF2, myocyte enhancer factor-2; MITR, myocyte enhancer factor-2-interacting transcription repressor; TSA, trichostatin; GST, glutathione S-transferase; PAGE, polyacrylamide gel electrophoresis.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES


1. Kuo, M. H., and Allis, C. D. (1998) Bioessays 20, 615-626[CrossRef][Medline] [Order article via Infotrieve]
2. Taunton, J., Hassig, C. A., and Schreiber, S. L. (1996) Science 272, 408-411[Abstract]
3. Yang, W. M., Inouye, C., Zeng, Y., Bearss, D., and Seto, E. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 12845-12850[Abstract/Free Full Text]
4. Dangond, F., Hafler, D. A., Tong, J. K., Randall, J., Kojima, R., Utku, N., and Gullans, S. R. (1998) Biochem. Biophys. Res. Commun. 242, 648-652[CrossRef][Medline] [Order article via Infotrieve]
5. Emiliani, S., Fischle, W., Van Lint, C., Al-Abed, Y., and Verdin, E. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 2795-2800[Abstract/Free Full Text]
6. Grozinger, C. M., Hassig, C. A., and Schreiber, S. L. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 4868-4873[Abstract/Free Full Text]
7. Miska, E. A., Karlsson, C., Langley, E., Nielsen, S. J., Pines, J., and Kouzarides, T. (1999) EMBO J. 18, 5099-5107[Abstract/Free Full Text]
8. Wang, A. H., Bertos, N. R., Vezmar, M., Pelletier, N., Crosato, M., Heng, H. H., Th'ng, J., Han, J., and Yang, X. J. (1999) Mol. Cell. Biol. 19, 7816-7827[Abstract/Free Full Text]
9. Huang, E. Y., Zhang, J., Miska, E. A., Guenther, M. G., Kouzarides, T., and Lazar, M. A. (2000) Genes Dev. 14, 45-54[Abstract/Free Full Text]
10. Kao, H. Y., Downes, M., Ordentlich, P., and Evans, R. M. (2000) Genes Dev. 14, 55-66[Abstract/Free Full Text]
11. Sparrow, D. B., Miska, E. A., Langley, E., Reynaud-Deonauth, S., Kotecha, S., Towers, N., Spohr, G., Kouzarides, T., and Mohun, T. J. (1999) EMBO J. 18, 5085-5098[Abstract/Free Full Text]
12. Zhou, X., Richon, V. M., Rifkind, R. A., and Marks, P. A. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 1056-1061[Abstract/Free Full Text]
13. Lu, J., McKinsey, T. A., Nicol, R. L., and Olson, E. N. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 4070-4075[Abstract/Free Full Text]
14. Lemercier, C., Verdel, A., Galloo, B., Curtet, S., Brocard, M. P., and Khochbin, S. (2000) J. Biol. Chem. 275, 15594-15599[Abstract/Free Full Text]
15. Black, B. L., and Olson, E. N. (1998) Annu. Rev. Cell Dev. Biol. 14, 167-196[CrossRef][Medline] [Order article via Infotrieve]
16. Molkentin, J. D., Lu, J., Antos, C. L., Markham, B., Richardson, J., Robbins, J., Grant, S., and Olson, E. N. (1998) Cell 93, 215-228[Medline] [Order article via Infotrieve]
17. Nagy, L., Kao, H. Y., Chakravarti, D., Lin, R. J., Hassig, C. A., Ayer, D. E., Schreiber, S. L., and Evans, R. M. (1997) Cell 89, 373-380[Medline] [Order article via Infotrieve]
18. Boyd, J. M., Subramanian, T., Schaeper, U., La Regina, M., Bayley, S., and Chinnadurai, G. (1993) EMBO J. 12, 469-478[Abstract]
19. Schaeper, U., Boyd, J. M., Verma, S., Uhlmann, E., Subramanian, T., and Chinnadurai, G. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 10467-10471[Abstract]
20. Turner, J., and Crossley, M. (1998) EMBO J. 17, 5129-5140[Abstract/Free Full Text]
21. Sewalt, R. G., Gunster, M. J., van der Vlag, J., Satijn, D. P., and Otte, A. P. (1999) Mol. Cell. Biol. 19, 777-787[Abstract/Free Full Text]
22. Criqui-Filipe, P., Ducret, C., Maira, S. M., and Wasylyk, B. (1999) EMBO J. 18, 3392-3403[Abstract/Free Full Text]
23. Postigo, A. A., and Dean, D. C. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 6683-6688[Abstract/Free Full Text]
24. Meloni, A. R., Smith, E. J., and Nevins, J. R. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 9574-9579[Abstract/Free Full Text]
25. Vliet, J., Turner, J., and Crossley, M. (2000) Nucleic Acids Res. 28, 1955-1962[Abstract/Free Full Text]
26. Furusawa, T., Moribe, H., Kondoh, H., and Higashi, Y. (1999) Mol. Cell. Biol. 19, 8581-8590[Abstract/Free Full Text]
27. Sundqvist, A., Sollerbrant, K., and Svensson, C. (1998) FEBS Lett. 429, 183-188[CrossRef][Medline] [Order article via Infotrieve]
28. Nibu, Y., Zhang, H., and Levine, M. (1998) Science 280, 101-104[Abstract/Free Full Text]
29. Luo, R. X., Postigo, A. A., and Dean, D. C. (1998) Cell 92, 463-473[Medline] [Order article via Infotrieve]
30. Fischle, W., Emiliani, S., Hendzel, M. J., Nagase, T., Nomura, N., Voelter, W., and Verdin, E. (1999) J. Biol. Chem. 274, 11713-11720[Abstract/Free Full Text]
31. Verdel, A., and Khochbin, S. (1999) J. Biol. Chem. 274, 2440-2445[Abstract/Free Full Text]
32. Edmondson, D. G., Lyons, G. E., Martin, J. F., and Olson, E. N. (1994) Development (Camb.) 120, 1251-1263[Abstract/Free Full Text]
33. Lyons, G. E., Micales, B. K., Schwarz, J., and Olson, E. N. (1995) J. Neurosci. 15, 5727-5738[Abstract]
34. Lu, J., McKinsey, T. A., Zhang, C. L., and Olson, E. N. (2000) Mol. Cell 6, 233-244[Medline] [Order article via Infotrieve]
35. McKinsey, T. A., Zhang, C. L., Lu, J., and Olson, E. N. (2000) Nature 408, 106-111[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.